Companies
Sanofi
PharmaceuticalsParis, FranceSNY74,846 employees
More about Sanofi
Drugmaker that develops and sells prescription medicines and vaccines for immune, rare and chronic diseases
Revenue
€43.6B
Fiscal 2025 net sales, up 6.2%
Employees
74,846
As of December 2025
Stock
SNY
Nasdaq
Headquarters
Paris, France
CEO
Belén Garijo
Since May 2026
BrandsDupixent, Beyfortus, Altuviiio, Sarclisa, Sanofi Pasteur vaccines
Current strategyNew CEO named to bring more rigor to execution, with research and development productivity as the main priority
Recent workforce changesHeadcount fell by 8,032 in 2025, partly from excluding Opella; 229 roles cut at Blueprint Medicines starting October 2026
CompetitorsGSK, Pfizer, Novartis
Related companiesGSKNovartisNovo Nordisk
Checked October 11, 2026 · Sources: sec.gov, sanofi.com, pharmexec.com, guidechem.com
No source-backed updates for Sanofi yet. They appear here when a public report or filing covers the company.
No one has posted about Sanofi yet. Be the first to post ›
Follow Sanofi in a feed reader, no account needed: RSS feed